Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Net Income (2022 - 2025)

Cannabis Bioscience International Holdings' Net Income history spans 3 years, with the latest figure at -$113737.0 for Q4 2025.

  • For Q4 2025, Net Income fell 60.58% year-over-year to -$113737.0; the TTM value through Nov 2025 reached -$456484.0, up 14.4%, while the annual FY2025 figure was -$421365.0, 34.2% up from the prior year.
  • Net Income for Q4 2025 was -$113737.0 at Cannabis Bioscience International Holdings, down from -$92152.0 in the prior quarter.
  • Across five years, Net Income topped out at -$70827.0 in Q4 2024 and bottomed at -$284868.0 in Q1 2023.
  • The 3-year median for Net Income is -$124682.0 (2023), against an average of -$154743.7.
  • The largest annual shift saw Net Income surged 54.75% in 2024 before it crashed 60.58% in 2025.
  • A 3-year view of Net Income shows it stood at -$124428.0 in 2023, then soared by 43.08% to -$70827.0 in 2024, then plummeted by 60.58% to -$113737.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Net Income are -$113737.0 (Q4 2025), -$92152.0 (Q3 2025), and -$101387.0 (Q2 2025).